의약품용 젤라틴 시장 : 공급원, 유형, 기능 및 용도별 - 세계 예측(2025-2030년)

The Pharmaceutical Gelatin Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.44%, to USD 1.86 billion by 2030.

Pharmaceutical gelatin is a critical excipient used primarily in the formulation of capsule shells, tablets, and as a stabilizer in various medicinal products. Its necessity stems from its biocompatibility and ability to dissolve rapidly, making it ideal for drug delivery in the human body. Gelatin's most common applications are in soft gel capsules, hard capsules, and blood plasma substitutes. End-use sectors primarily include pharmaceutical companies manufacturing oral, ophthalmic, and topical delivery systems.

The market for pharmaceutical gelatin is significantly influenced by the rising demand for capsules due to their ease of consumption and improved bioavailability. An increasing geriatric population, alongside the surging occurrence of non-communicable diseases, boosts gelatin demand. Regulatory bodies' emphasis on improving drug delivery systems further fuels innovation in this sector. Notably, the market faces opportunities in developing plant-based gelatin alternatives, driven by a growing veganism trend and rising consumer awareness regarding animal welfare. Companies can capitalize on this by investing in R&D toward novel, sustainable gelatin formulations. Geographically, emerging markets in Asia-Pacific, particularly China and India, offer vast potential due to expanding healthcare infrastructure and rising consumer spending on pharmaceuticals.

However, the market confronts limitations, including stringent regulatory norms and volatility in raw material prices, especially concerning bovine and porcine sourcing due to disease outbreaks like Bovine Spongiform Encephalopathy (BSE). The challenge lies in balancing cost, quality, and compliance with international standards such as Good Manufacturing Practices (GMP).

Innovative areas include bio-engineered gelatin, which enhances molecular control over mechanical properties and stability, and gelatin's utilization in customized drug delivery systems. Moreover, collaborative research initiatives between pharmaceutical companies and research institutions may yield innovative product applications and formulations. The market demands agility, requiring firms to synchronize with technological advancements and evolving consumer preferences to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Large scale use of gelatin in pharma drug dosage
  • Prevalence of chronic and infectious disorders
  • Increasing clinical trials and preliminary drug studies
• Market Restraints
  • High cost associated with Pharmaceutical Gelatin
• Market Opportunities
  • Recent advancements in gelatin nanoparticle in vaccine and drug delivery
  • Improvements in supply chain and distribution network
• Market Challenges
  • Safety and quality concerns with pharmaceutical gelatin

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Gelatin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Gelatin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Gelatin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Gelatin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Gelatin Market

A detailed market share analysis in the Pharmaceutical Gelatin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Gelatin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Gelatin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Gelatin Market

A strategic analysis of the Pharmaceutical Gelatin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Gelatin Market, highlighting leading vendors and their innovative profiles. These include Gelco International, Gelita AG, Gelnex, Geltec Private Limited, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgel S.r.l., Junca Gelatines SL, Kenney & Ross Limited, Lapi Gelatine S.p.A, SAS Gelatines Weishardt, Tessenderlo Group NV, Toudongbao Biotechnology Co., Ltd., and Xiamen Gelken Gelatin Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Gelatin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Source, market is studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry.
• Based on Type, market is studied across Type A and Type B.
• Based on Function, market is studied across Gelling Agents, Stabilizing Agents, and Thickening Agents.
• Based on Application, market is studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Large scale use of gelatin in pharma drug dosage
    • 5.1.1.2. Prevalence of chronic and infectious disorders
    • 5.1.1.3. Increasing clinical trials and preliminary drug studies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with Pharmaceutical Gelatin
  • 5.1.3. Opportunities
    • 5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
    • 5.1.3.2. Improvements in supply chain and distribution network
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Gelatin Market, by Source

• 6.1. Introduction
• 6.2. Bovine Bone
• 6.3. Bovine Skin
• 6.4. Marine
• 6.5. Porcine
• 6.6. Poultry

7. Pharmaceutical Gelatin Market, by Type

• 7.1. Introduction
• 7.2. Type A
• 7.3. Type B

8. Pharmaceutical Gelatin Market, by Function

• 8.1. Introduction
• 8.2. Gelling Agents
• 8.3. Stabilizing Agents
• 8.4. Thickening Agents

9. Pharmaceutical Gelatin Market, by Application

• 9.1. Introduction
• 9.2. Absorbable Hemostats
• 9.3. Hard Capsules
• 9.4. Soft Capsules
• 9.5. Tablets

10. Americas Pharmaceutical Gelatin Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmaceutical Gelatin Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Gelatin Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Gelco International
• 2. Gelita AG
• 3. Gelnex
• 4. Geltec Private Limited
• 5. Geltech Co. Ltd.
• 6. Henan Boom Gelatin Co. Ltd.
• 7. India Gelatine & Chemicals Ltd.
• 8. Italgel S.r.l.
• 9. Junca Gelatines SL
• 10. Kenney & Ross Limited
• 11. Lapi Gelatine S.p.A
• 12. SAS Gelatines Weishardt
• 13. Tessenderlo Group NV
• 14. Toudongbao Biotechnology Co., Ltd.
• 15. Xiamen Gelken Gelatin Co., Ltd.